PROLOR Biotech, Inc. (PBTH)

[surf1944]

7:31AM PROLOR Biotech Receives Notice of Allowance for New U.S. Patent for Its Long-Acting Human Growth Hormone (PBTH) 5.06 : Co announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for a new patent application covering the company's long-acting CTP-enhanced human growth hormone (hGH-CTP). Upon issuance, the new patent would provide PROLOR with additional intellectual property protection covering methods for the induction of growth in growth hormone deficient patients. This new patent is the fourth hGH-CTP patent that has been allowed by the USPTO.